U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07453927) titled 'BLUE LIGHT FOR DONOR SITE HEALING IN BURN PATIENTS' on March 02.
Brief Summary: Background:
The donor site (DS) in patients with severe burns is often associated with complications that may delay healing and negatively affect clinical outcomes. Impaired re-epithelialization, pain, inflammation, and risk of infection represent relevant challenges in burn care. Blue light (BL) photobiomodulation has demonstrated beneficial effects in different types of skin lesions, including modulation of inflammation and stimulation of tissue repair. Therefore, BL therapy may represent an innovative and non-invasive strategy to enhance DS healing a...